Fischer Medical Ventures Limited Q2 FY26 earnings call summary

Earnings call of 7 Nov 2025, summarised by AI from the filing.

Fischer Medical Q2 FY26 revenue ₹86 cr (+118% YoY), EBITDA ₹19 cr, PAT ₹14 cr; expects equal Imaging-Preventive split in 2-3 years.

Key takeaways

1. Guidance Management expects revenue split between Imaging and Preventive Healthcare to be almost equal in 2-3 years; no revenue or margin guidance provided.
2. Driver Preventive Healthcare segment growth on early wellness initiatives, mental health and contactless screening adoption.
3. Risk International expansion slow due to pending regulatory approvals in individual countries.

Original filing on BSE

Fischer Medical Ventures Limited Q1 FY27 results

As filed: Revenue ₹81.9 cr (+256% year on year), EBITDA ₹11.3 cr (+125% year on year), PAT ₹3.8 cr (−24% year on year), EBITDA margin 13.7% (−801 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹97.7 cr, EBITDA ₹1.0 cr, PAT −₹7.1 cr, EBITDA margin 1.0%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹97.7 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +0.4% in 30 days (Nifty 500: +1.5%).
• Q3 FY26: Revenue ₹101 cr, EBITDA ₹21.6 cr, PAT ₹19.2 cr, EBITDA margin 21.3%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹101 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +1.9% in 28 days (Nifty 500: +0.4%).
• Q2 FY26: Revenue ₹86.0 cr, EBITDA ₹17.0 cr, PAT ₹14.0 cr, EBITDA margin 19.8%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹86.0 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −57.9% in 30 days (Nifty 500: +0.6%).
• Q1 FY26: Revenue ₹23.0 cr, EBITDA ₹5.0 cr, PAT ₹5.0 cr, EBITDA margin 21.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹23.0 cr). Scored once a year-earlier consolidated quarter exists.

Past price moves after results do not indicate future moves. Not a recommendation.

Fischer Medical Ventures Limited earnings call, investor presentation and press release summaries

• Q2 FY26: Earnings call (7 Nov 2025)